2 unknown, 1 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Donor Lymphocyte Infusion: new trials by email Literature Review of Donor Lymphocyte Infusion trials Research Report on Donor Lymphocyte Infusion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies Prophylactic DLI - Donor Lymphocyte Infusion, Peripheral Blood Stem Cell Transplantation | Phase 2 | Unknown | Chinese PLA General Hospital | 40 | 2019-01-01 | 2018-12-13 |
| Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotransplant donor lymphocyte infusion - Donor Lymphocyte Infusion, Allogeneic Hematopoietic Stem Cell Transplantation | Phase 2 | Unknown | Peking University People's Hospital | 40 | 2017-03-01 | 2020-03-10 |
| MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT donor lymphocyte infusion - Minimal Residual Disease, Donor Lymphocyte Infusion | Phase 2 / Phase 3 | Completed | Nanfang Hospital, Southern Medical University | 206 | 2016-01-01 | 2020-02-25 |
Recurrence (3) · Graft vs Host Disease (2) · Neoplasm, Residual (2)
Disease Attributes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Immune System Diseases (2) · Neoplasms (2) · Neoplastic Processes (2)
Decitabine (1) · Drug Therapy (1)
Chinese PLA General Hospital (1) · Nanfang Hospital, Southern Medical University (1) · Peking University People's Hospital (1)
China (3)
Qifa Liu (1) · Xiao-jun Huang (1)